Veracyte VP has 1,361 shares withheld for taxes

VERACYTE, INC. executive Jonathan Wygant, VP and Chief Accounting Officer, reported a tax-related share disposition in company stock.

Rhea-AI Filing Summary

VERACYTE, INC. executive Jonathan Wygant, VP and Chief Accounting Officer, reported a tax-related share disposition in company stock. On June 2, 2026, 1,361 shares of common stock were withheld to satisfy his tax withholding obligations tied to the vesting of restricted stock units and did not represent a sale. Following this withholding, he directly holds 44,073 shares of Veracyte common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 1,361 shares

Exercise Price or Tax Liability 1 txn

Insider Wygant Jonathan

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,361	$47.80	$65K

Holdings After Transaction: Common Stock — 44,073 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.

Key Figures

Shares withheld for taxes: 1,361 shares Transaction price per share: $47.80 per share Shares held after transaction: 44,073 shares

3 metrics

Shares withheld for taxes 1,361 shares Common stock withheld for tax obligations on June 2, 2026

Transaction price per share $47.80 per share Price associated with tax withholding of 1,361 shares

Shares held after transaction 44,073 shares Direct Veracyte common stock holdings after withholding

Key Terms

restricted stock units, tax withholding obligations, Common Stock

3 terms

restricted stock units financial

"in connection with the vesting of certain restricted stock units on June 2, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting"

Common Stock financial

"Represents shares of common stock withheld to satisfy the Reporting Person's tax"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Veracyte (VCYT) executive Jonathan Wygant report in this Form 4?

Jonathan Wygant reported 1,361 Veracyte common shares withheld for taxes. The withholding covered tax obligations from vesting restricted stock units on June 2, 2026, and was not an open-market sale. After this transaction, he directly holds 44,073 Veracyte shares.

Was the Veracyte (VCYT) Form 4 transaction a stock sale by Jonathan Wygant?

No, the Form 4 transaction was not a stock sale. The 1,361 shares were withheld by Veracyte to satisfy Jonathan Wygant’s tax withholding obligations from RSU vesting, as the footnote explicitly states the event does not represent a sale.

How many Veracyte (VCYT) shares were withheld for Jonathan Wygant’s taxes?

A total of 1,361 Veracyte common shares were withheld for taxes. These shares covered Jonathan Wygant’s tax withholding obligations arising from the vesting of certain restricted stock units on June 2, 2026, according to the Form 4 disclosure and accompanying footnote.

What is Jonathan Wygant’s Veracyte (VCYT) shareholding after this Form 4 event?

After the tax withholding transaction, Jonathan Wygant directly holds 44,073 Veracyte common shares. This post-transaction balance reflects his remaining stake following the withholding of 1,361 shares to meet tax obligations related to restricted stock unit vesting.

What price per share is reported in Jonathan Wygant’s Veracyte (VCYT) Form 4?

The Form 4 lists a transaction price of $47.80 per Veracyte share. This price is associated with the 1,361 common shares withheld to satisfy Jonathan Wygant’s tax withholding obligations arising from the vesting of restricted stock units on June 2, 2026.

What triggered the tax withholding transaction in Veracyte (VCYT) stock for Jonathan Wygant?

The tax withholding was triggered by the vesting of certain restricted stock units on June 2, 2026. To satisfy Jonathan Wygant’s tax obligations from that vesting, 1,361 Veracyte common shares were withheld, as clearly noted in the Form 4 footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 09:38 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wygant Jonathan

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2026		F(1)		1,361	D	$47.8	44,073	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.

Remarks:

	/s/ Jonathan Wygant	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)